Baird Medical Investment (BDMD) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkyAI (SKYA) has outperformed Baird Medical Investment (BDMD) over the past year, losing 23.0% versus a loss of 93.6%. SkyAI is the larger company by market cap ($7.8 million vs $5.1 million), about 1.5 times the size. Baird Medical Investment converts more of its revenue into profit, with a net margin of -121.0% versus -138400.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDMD | SKYA |
|---|---|---|
| Share price | $0.0897 | $2.18 |
| Market cap | $5.07M | $7.82M |
| 1-day change | -12.91% | -45.50% |
| YTD return | -93.40% | +7.39% |
| 1-year return | -93.64% | -22.97% |
| P/E ratio (TTM) | — | 2.83 |
| Forward P/E | 0.64 | — |
| EPS (TTM) | $-0.55 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.54M | $204.12K |
| Revenue growth (YoY) | -39.15% | — |
| Net income (latest FY) | $-27.28M | $-282.50M |
| Gross margin | 83.79% | -202.49% |
| Operating margin | -113.73% | -132145.49% |
| Net margin | -121.04% | -138400.02% |
| 52-week high | $3.70 | $4.39 |
| 52-week low | $0.073 | $0.91 |
| Distance from 52-week high | -97.58% | -50.34% |
| Analyst consensus | none | — |
| Avg. price target upside | +4359.31% | — |
| Average volume | 16.31M | 1.74M |
| Shares outstanding | 56.52M | 3.59M |
| Employees | 146 | 30 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKYA has outperformed BDMD by 70.7 percentage points over the past year.
- Baird Medical Investment is more profitable, keeping -121.0 cents of every revenue dollar as net income versus -138400.0 cents for SkyAI.
About Baird Medical Investment
BDMD stock →Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.
Health Care · Medical/Dental Instruments · 146 employees
About SkyAI
SKYA stock →SkyAI, Inc., a financial technology company with a Solana digital asset treasury that is building an agentic finance platform. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa.
Health Care · Medical/Dental Instruments · 30 employees
BDMD vs SKYA FAQ
Which is bigger, Baird Medical Investment or SkyAI?
SkyAI (SKYA) is larger, with a market capitalization of $7.82M compared with $5.07M for Baird Medical Investment (BDMD).
Which stock has performed better over the past year, BDMD or SKYA?
SKYA returned -22.97% over the past 12 months, compared with -93.64% for BDMD (price return, excluding dividends). Past performance does not predict future results.
Are Baird Medical Investment and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.